Table 1.
Preoperative characteristics of diabetics and non-diabetics who received intracameral ICMA or a topical regimen for cataract surgery (ITT set)
| Diabetics | Non-Diabetics | |||
|---|---|---|---|---|
| ICMA Group (N = 24) | Topical Group (N = 33) | ICMA Group (N = 271) | Topical Group (N = 263) | |
| Gender | ||||
| Male, n (%) | 15 (62.5) | 18 (54.5) | 105 (38.7) | 116 (44.1) |
| Female, n (%) | 9 (37.5) | 15 (45.5) | 166 (61.3) | 147 (55.9) |
| Age (years) | ||||
| n | 24 | 31 | 251 | 255 |
| Mean ± SD | 70.4 ± 9.2 | 72.2 ± 8.0 | 69.1 ± 9.5 | 70.4 ± 9.3 |
| Min – Max | 48–85 | 52–84 | 43–87 | 34–88 |
| Time since cataract diagnosis (months) | ||||
| n | 24 | 31 | 252 | 255 |
| Median | 4.2 | 2.8 | 4.3 | 4.2 |
| Min – Max | 0.3–134.7 | 0.2–57.5 | 0.0–636.6 | 0.0–111.9 |
| Visible iris diameter at selection (mm) | ||||
| n | 23 | 32 | 263 | 255 |
| Mean ± SD | 11.5 ± 0.4 | 11. 8 ± 0.5 | 11. 9 ± 0.6 | 11.9 ± 0.5 |
| Min – Max | 10.9–12.5 | 10.7–12.7 | 10.0–14.0 | 10.0–13.5 |
SD standard deviation, n number of patients, Min minimum, Max maximum, ICMA Group = patients who received an intracameral injection of a standardized combination of 1% lidocaine, 0.02% tropicamide, and 0.31% phenylephrine immediately after the 1st corneal incision; Topical Group = patients who received a topical regimen of 1 drop each of 10% phenylephrine and 0.5% tropicamide